Literature DB >> 4073866

In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.

J G Morris, J H Tenney, G L Drusano.   

Abstract

The in vitro activity of norfloxacin and six other antimicrobial agents was tested against 93 vibrio strains representing the currently described pathogenic Vibrio species. Norfloxacin had excellent activity against all species, with the following MICs for 90% of the strains: 0.016 micrograms/ml for Vibrio cholerae (including tetracycline-resistant V. cholerae O1 strains), 0.25 micrograms/ml for V. parahaemolyticus, and 0.063 micrograms/ml for V. vulnificus.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4073866      PMCID： PMC180271          DOI： 10.1128/AAC.28.3.442

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Optimal antibiotic therapy in cholera.

Authors:  C K Wallace; P N Anderson; T C Brown; S R Khanra; G W Lewis; N F Pierce; S N Sanyal; G V Segre; R H Waldman
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

2.  Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania.

Authors:  F S Mhalu; P W Mmari; J Ijumba
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

Review 3.  Cholera and other vibrioses in the United States.

Authors:  J G Morris; R E Black
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

4.  The pharmacokinetics and tissue penetration of norfloxacin.

Authors:  Z N Adhami; R Wise; D Weston; B Crump
Journal:  J Antimicrob Chemother       Date:  1984-01       Impact factor: 5.790

5.  In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.

Authors:  S Nakamura; A Minami; H Katae; S Inoue; J Yamagishi; Y Takase; M Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

6.  Plasmid-borne multiple drug resistance in Vibrio cholerae serogroup O1, biotype El Tor: evidence for a point-source outbreak in Bangladesh.

Authors:  R I Glass; M I Huq; J V Lee; E J Threlfall; M R Khan; A R Alim; B Rowe; R J Gross
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

7.  Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.

Authors:  L J Goodman; R M Fliegelman; G M Trenholme; R L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Endemic cholera in rural Bangladesh, 1966-1980.

Authors:  R I Glass; S Becker; M I Huq; B J Stoll; M U Khan; M H Merson; J V Lee; R E Black
Journal:  Am J Epidemiol       Date:  1982-12       Impact factor: 4.897

9.  Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors:  J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Campylobacter enteritis in the United States. A multicenter study.

Authors:  M J Blaser; J G Wells; R A Feldman; R A Pollard; J R Allen
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391
View more
  13 in total

1.  Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.

Authors:  J Okuda; E Hayakawa; M Nishibuchi; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.

Authors:  S K Bhattacharya; M K Bhattacharya; P Dutta; D Dutta; S P De; S N Sikdar; A Maitra; A Dutta; S C Pal
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Quantitative PCR and in vivo efficacy of antibiotics in the treatment of Vibrio vulnificus infection in a mouse model.

Authors:  G P Neupane; D-M Kim; N R Yun; S-H Shin; S-C Lim; C-H Choi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-21       Impact factor: 3.267

4.  In vitro antimicrobial susceptibility of Vibrio vulnificus isolated in Taiwan.

Authors:  P R Hsueh; J C Chang; S C Chang; S W Ho; W C Hsieh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

Review 5.  Cholera.

Authors:  J B Kaper; J G Morris; M M Levine
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

6.  Construction of a tetracycline inducible expression vector and characterization of its use in Vibrio cholerae.

Authors:  X Renee Bina; Eileen A Wong; Thomas F Bina; James E Bina
Journal:  Plasmid       Date:  2014-10-24       Impact factor: 3.466

7.  Vitek system antimicrobial susceptibility testing of O1, O139, and non-O1 Vibrio cholerae.

Authors:  C V Sciortino; J A Johnson; A Hamad
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.

Authors:  R Vanhoof; J M Hubrechts; E Roebben; H J Nyssen; E Nulens; J Leger; N De Schepper
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

Review 9.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 10.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.